2 completed, 1 recruiting, 1 terminated. 3 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
Follow Hemoglobin S Disease: new trials by email Literature Review of Hemoglobin S Disease trials Research Report on Hemoglobin S Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD TCRα/β+ and CD19+ depleted haploidentical stem cell transplantation, Matched sibling donor transplantation - HbS Disease, Hemoglobin S Disease | Phase 2 | Recruiting | University of Regensburg | 212 | 2021-06-30 | 2024-05-13 |
| Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients Training Program - Sickle Cell Hemoglobin C Disease, Hemoglobin S Disease | Not applicable | Completed | Centre Hospitalier Universitaire de Saint Etienne | 40 | 2014-09-01 | 2021-09-13 |
| Effects of HQK-1001 in Patients With Sickle Cell Disease HQK-1001, Placebo - Sickle Cell Disease, Sickle Cell Anemia | Phase 2 | Terminated | HemaQuest Pharmaceuticals Inc. | 77 | 2012-07-01 | 2015-03-18 |
| A Study of HQK-1001 in Patients With Sickle Cell Disease HQK-1001 - Sickle Cell Disease, Sickle Cell Anemia | Phase 2 | Completed | HemaQuest Pharmaceuticals Inc. | 52 | 2011-04-01 | 2013-06-19 |
Anemia, Sickle Cell (4) · Hemoglobin SC Disease (1)
Anemia (4) · Anemia, Hemolytic (4) · Anemia, Hemolytic, Congenital (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Genetic Diseases, Inborn (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Hemoglobinopathies (4)
HemaQuest Pharmaceuticals Inc. (2) · Centre Hospitalier Universitaire de Saint Etienne (1) · University of Regensburg (1)
Canada (2) · Egypt (2) · Jamaica (2) · Lebanon (2) · United States (2) · Austria (1) · France (1) · Germany (1)
Richard Ghalie, MD, MBA (2) · Selim Corbacioglu, MD (1)
PMID 23828223, PMID 24677033, PMID 30389037, PMID 31742587, PMID 32681734